| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/26/1994 | CA2149116A1 Compositions for the regulation of cytokine activity |
| 05/26/1994 | CA2149046A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | CA2148930A1 Substituted amidino compounds, their manufacture and methods of treatment |
| 05/26/1994 | CA2148835A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
| 05/26/1994 | CA2148819A1 Water soluble camptothecin derivatives |
| 05/26/1994 | CA2148383A1 Peptide inhibitors of fibronectin and related collagen-binding proteins |
| 05/26/1994 | CA2147503A1 Substituted dipeptide analogs promote release of growth hormone |
| 05/26/1994 | CA2136077A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
| 05/25/1994 | EP0598702A1 Biphenylmethane derivative, the use of it and pharmacological compositions containing same |
| 05/25/1994 | EP0597997A1 Lanthionine bridged peptides |
| 05/25/1994 | EP0597847A1 Synthetic senescent cell antigen |
| 05/25/1994 | EP0597831A1 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| 05/25/1994 | EP0434833B1 9-fluor-prostaglandine derivates, their process of production and their pharmaceutical use |
| 05/25/1994 | CN1087092A New 7 beta-substituted-4-aza-5 alpha-androstan-3-ones as 5 alpha-reductase inhibitors |
| 05/25/1994 | CN1087084A New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloa lkylacetamides |
| 05/25/1994 | CN1087080A Benzenealkanoic acids for cardiovascular diseases |
| 05/25/1994 | CN1024667C Process for preparing substituted aminomethytetralins and their heterocyclic analogues |
| 05/25/1994 | CN1024665C Ring-substituted 2-amino-1,2,3-tetrahydronaphthalenes and its producing process |
| 05/24/1994 | US5315012 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds |
| 05/24/1994 | US5314906 Derivatives of physostigmine, their use and pharmaceutical formulations containing them |
| 05/24/1994 | US5314896 Dopaminergic agents, antipsychotic and hypotensive agents |
| 05/24/1994 | US5314891 Lipoxygenase inhibitors |
| 05/24/1994 | US5314889 Hormone antagonists |
| 05/24/1994 | US5314886 N-substituted lactams useful as cholecystokinin antagonists |
| 05/24/1994 | US5314881 Wound healing |
| 05/24/1994 | CA1329862C Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors |
| 05/24/1994 | CA1329774C Methods for the treatment of osteoporosis and related disorders |
| 05/19/1994 | DE4238778A1 Vektor zur Expression von therapeutisch relevanten Genen Vector for Expression of therapeutically relevant genes |
| 05/18/1994 | EP0597503A2 ECK receptor ligands |
| 05/18/1994 | EP0597088A1 Novel imidazole derivatives, their preparation and therapeutic applications |
| 05/18/1994 | EP0596933A1 5-ht4 receptor antagonists |
| 05/18/1994 | EP0596891A1 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles, their preparation and their use |
| 05/18/1994 | EP0548177B1 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases |
| 05/18/1994 | EP0328552B1 Thrombin derived polypeptides, compositions and methods for use |
| 05/18/1994 | EP0248819B1 Recombinant fibroblast growth factors |
| 05/18/1994 | CN1086824A Calcium channel blocking polypeptide from agelenopsis aperta |
| 05/18/1994 | CN1086821A Novel thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| 05/18/1994 | CN1086819A Novel compounds |
| 05/18/1994 | CN1086812A Process for preparing novel aromatase inhibiting 4(5)-imidazoles |
| 05/18/1994 | CN1086811A Novel nicotincacid esters |
| 05/18/1994 | CN1086806A Substituted cyclohexane derivative for treatment of illness |
| 05/18/1994 | CN1086709A Compositions containing retionic acids and tocopherol |
| 05/18/1994 | CN1024557C Process for composition containing associated compound of hyaluronic acid |
| 05/18/1994 | CN1024552C Process for pyridoindole derivatives |
| 05/17/1994 | US5312936 Angiotensin II antagonists |
| 05/17/1994 | US5312916 Hydrogenating 6-phthalimidomethyl-5H-dibenz/b,e/azepine with palladium/charcoal, reacting product with hydrazine, reacting product with bromocyanogen, precipitating in presence of dimethylformamide and hydrogen chloride |
| 05/17/1994 | US5312831 Immunology, anticarcinogenic agents and AIDS treatment |
| 05/17/1994 | US5312825 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity |
| 05/17/1994 | US5312821 Antiulcer agents |
| 05/17/1994 | US5312818 (Interphenylene)7-oxabicycloheptane substituted (di)amide prostaglandin analog |
| 05/17/1994 | US5312817 Treatment of fatigue syndrome |
| 05/17/1994 | US5312816 Method of combatting osteoporosis in mammalian subjects, utilizing organic boron compounds |
| 05/17/1994 | US5312815 Fungicidal (+)-2-(2,4-difluorophenyl)-3-methyl-1-(1H-1,2,4-triazol-1-yl)3-(6-(1H-1,2,4-triazol-1-yl)pyridazin-3-ylthio) butan-2-ol |
| 05/17/1994 | US5312809 Physiologically active substance derived from malt and process for the production thereof |
| 05/17/1994 | US5312629 Method for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases |
| 05/17/1994 | US5312625 Fused 7-membered cyclic compound and antipsychotic preparation containing the same |
| 05/17/1994 | CA1329617C Resolved amino pyrrolidine neuroprotective agents |
| 05/17/1994 | CA1329616C Aromatase inhibiting 4(5)-imidazoles |
| 05/17/1994 | CA1329541C Pharmaceutical composition for relieving side effects of platinum-containing drugs |
| 05/11/1994 | WO1994010324A1 Ws79089 substances from streptosporangium |
| 05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
| 05/11/1994 | WO1994010207A2 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 05/11/1994 | WO1994010203A2 Op-3-induced morphogenesis |
| 05/11/1994 | WO1994010197A1 A novel protein tyrosine kinase |
| 05/11/1994 | WO1994010196A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 05/11/1994 | WO1994010195A1 Calcium channel blocking polypeptides from heteropoda venatoria |
| 05/11/1994 | WO1994010193A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 05/11/1994 | WO1994010187A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b) |
| 05/11/1994 | WO1994010178A1 6-(substituted methylene) penems and intermediates |
| 05/11/1994 | WO1994010174A1 Piperidine derivatives as 5-ht4 receptor antagonists |
| 05/11/1994 | WO1994010171A1 5-arylindole derivatives and their use as serotonin (5-ht1) agonists |
| 05/11/1994 | WO1994010170A1 Substituted quinuclidines as substance p antagonists |
| 05/11/1994 | WO1994010165A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 05/11/1994 | WO1994010162A1 Dopamine receptor subtype ligands |
| 05/11/1994 | WO1994010157A1 Styrene derivative and salts thereof |
| 05/11/1994 | WO1994010148A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
| 05/11/1994 | WO1994010146A1 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists |
| 05/11/1994 | WO1994010144A1 Indolylcarbamates as anti-inflammatory agents |
| 05/11/1994 | WO1994010142A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 05/11/1994 | WO1994010139A1 Novel vitamin d analogues |
| 05/11/1994 | WO1994010138A1 Inhibitors of farnesyl-protein transferase |
| 05/11/1994 | WO1994010127A1 Tartronic acids, their acetalic ethers and o-esters |
| 05/11/1994 | WO1994010118A1 Tri-substituted phenyl derivatives and processes for their preparation |
| 05/11/1994 | WO1994009806A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders |
| 05/11/1994 | WO1994009801A1 Free active oxygen radical scavenger |
| 05/11/1994 | WO1994009781A1 Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection |
| 05/11/1994 | WO1994009766A1 Inhibitors of farnesyl-protein transferase |
| 05/11/1994 | WO1994006919A3 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
| 05/11/1994 | EP0596406A1 Imidazo (1,2-a) Pyridines as bradykinin antagonists |
| 05/11/1994 | EP0596326A1 Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing the same, use thereof and precesses for their production |
| 05/11/1994 | EP0595924A1 Platelet activating factor antagonists |
| 05/11/1994 | EP0595910A1 S-(3-(4(5))-imidazolyl)propyl)isothiourea as selective trhistomine h3 receptor antagonist |
| 05/11/1994 | EP0595878A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 05/11/1994 | EP0595826A1 2'-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents |
| 05/11/1994 | EP0595798A1 Bispecific heteroantibodies with dual effector functions |
| 05/11/1994 | EP0595796A1 Method of treatment of androgen-related diseases |
| 05/11/1994 | CN1086422A Novel compositions containing hyaluronic acid associates and a process for preparing same |
| 05/11/1994 | CA2148700A1 Piperidine derivatives as 5-ht4 receptor antagonists |
| 05/11/1994 | CA2148693A1 Tartronic acids, their acetalic ethers and o-esters |
| 05/11/1994 | CA2148685A1 Truncated insulin-like growth factor binding proteins having mitogenic activity |